✦ LIBER ✦

Conversion from trough (C0) to 2 hour (C2) monitoring of cyclosporine level in pediatric heart transplant patients—an intent-to-treat study

✍ Scribed by C.E. Canter; S.P. Hmiel; R.W. Shepherd; S.A. Lassa-Claxton; M. Landt

Book ID: 116518583
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 64 KB
Volume: 24
Category: Article
ISSN: 1557-3117
DOI: 10.1016/j.healun.2004.11.307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

121: Determination of C2 trough levels o

121: Determination of C2 trough levels of cyclosporine is superior to C0 measurement for rejection monitoring in pediatric heart transplant patients

✍ S. Schubert; H. Lehmkuhl; H. Abdul-Khaliq; O. Miera; N. Hiemann; M. Huebler; Y. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Switching monitoring of emulsified cyclo

Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients

✍ Pieter Langers; Serge C.L.M. Cremers; Jan den Hartigh; Roeland A. Veenendaal; W. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

After orthotopic liver transplantation (OLT) many patients use emulsified cyclosporine. Recent data showed that blood levels 2 hours after dosing (C-2) better reflect systemic exposure to the drug (area under the blood concentration time curve) than trough levels (C-0) do. We investigated difference

Conversion of C-0 to C-2 monitoring of c

Conversion of C-0 to C-2 monitoring of cyclosporine in stable kidney transplant patients

✍ So Jirasiritham; V Mavichak; K Danviriyasup; S Jirasiritham 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Assessment of Cyclosporine Pharmacokinet

Assessment of Cyclosporine Pharmacokinetic Parameters to Facilitate Conversion From C0 to C2 Monitoring in Heart Transplant Recipients

✍ R.A. Davies; J.P. Veinot; K. Williams; H. Haddad; A. Baker; J. Donaldson; C. Pug 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Impact of late conversion from C0 to C2

Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients

✍ Mitsuhisa Takatsuki; Chao-Long Chen; Yaw-Sen Chen; Chih-Chi Wang; Chih-Che Lin; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Clinical benefit of neoral dose monitori

Clinical benefit of neoral dose monitoring with cyclosporine 2-hour peak levels compared to trough levels in stable heart transplant patients

✍ M. Cantarovich; E. Elstein; C. Magnan; R. Chartier; B. de Varennes 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB